Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
September 20, 2021IMW 2021: MRD in myeloma21 minutesPlayMeasurable residual disease (MRD) is emerging as an important prognostic marker in the management of multiple myeloma. Promising clinical evidence......moreShareView all episodesBy VJHemOnc4.522 ratingsSeptember 20, 2021IMW 2021: MRD in myeloma21 minutesPlayMeasurable residual disease (MRD) is emerging as an important prognostic marker in the management of multiple myeloma. Promising clinical evidence......moreMore shows like VJHemOnc PodcastView allNEJM This Week318 ListenersPeerView Oncology & Hematology CME/CNE/CPE Video Podcast11 ListenersTreating Blood Cancers12 ListenersBlood Podcast51 ListenersBlood Cancer Talks51 Listeners
Measurable residual disease (MRD) is emerging as an important prognostic marker in the management of multiple myeloma. Promising clinical evidence...
September 20, 2021IMW 2021: MRD in myeloma21 minutesPlayMeasurable residual disease (MRD) is emerging as an important prognostic marker in the management of multiple myeloma. Promising clinical evidence......more
Measurable residual disease (MRD) is emerging as an important prognostic marker in the management of multiple myeloma. Promising clinical evidence...